FBIOX Rating, Research - Fidelity Select Biotechnology

Fidelity Select Biotechnology (fbiox)

Last Updated by Anonymous | Update This Page Now

►Summary | Add New Mutual Fund | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands


Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 18

Threats + Weaknesses = 13

When strengths & opportunities substantially exceed threats & weaknesses an investment in the fbiox mutual fund has great long term potential.

Fund Management Team

Fund Description Update

Fidelity Select Biotechnology (FBIOX) Description: FBIOX is a mutual fund, which is an investment that owns a basket of assets. The FBIOX mutual fund was provided by Fidelity and this investment vehicle derives the majority of its value from equity holdings (stocks). Fidelitys mutual fund has a medium management tenure and is in the large fund size classification. FBIOXs minimum initial investment amount is $2500 while the IRA minimum is $2500. FBIOXs expense ratio is roughly 1%. The latest FBIOXs front end load was 0% and the back end load was 0%. The Fidelity Select Biotechnology (FBIOX) mutual fund falls under the health category. FBIOX focuses its investments in USA and FBIOX is focused on the health industry or fund sector. The Fidelity Select Biotechnology (FBIOX) mutual fund is not a leveraged fund and it does not have inverse fund properties. An investor can find FBIOXs top holdings, fundamental analysis, ratings, and fund risk (volatility) on the left side of the screen. The right side of FBIOXs research report features technical analysis and long term investment potential.

Portfolio Strategy Update

This investment vehicle seeks capital appreciation. The fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. These companies may include, companies involved in the research, development, or production of pharmaceuticals, including veterinary drugs. It may invest in securities of foreign issuers. The funds non-diversified.

Management Analysis Update

Fidelity Select Biotechnology's executives / managers make better investing decisions, because their assets are invested along side their client's. Fidelity Select Biotechnology has a consistent strategy that will help it to outperform in the future.

Performance Analysis Update